Pill with imprint 54 414 is White, Round and has been identified as Everolimus 0.25 mg. It is supplied by Hikma Pharmaceuticals PLC.

Everolimus is used in the treatment of Neuroendocrine Carcinoma; Breast Cancer; Organ Transplant, Rejection Prophylaxis; Renal Angiomyolipoma; Tuberous Sclerosis Complex and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Everolimus 0.25 mg is not a controlled substance under the Controlled Substances Act (CSA).